Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and Management

Author： Graham Johnny   Coghill David  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.22, Iss.3, 2008-01, pp. : 213-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Attention-Deficit Hyperactivity Disorder in Girls: Epidemiology and Management

By Staller Jud   Faraone Stephen V.  

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 107-123

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults

By Santosh Paramala J.   Sattar Sanjida  

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 737-763

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: A Systematic Literature Review

By Wu Eric Q.  

CNS Drugs, Vol. 26, Iss. 7, 2012-07 ,pp. : 581-600

Adis International

Access to resources Recommend Favorite

Pharmacological management of attention-deficit hyperactivity disorder

By Reeves Gloria   Schweitzer Julie  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1313-1320

Informa Healthcare

Access to resources Recommend Favorite

Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects

By  

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 590-594

Bentham Science Publishers

Access to resources Recommend Favorite